Published in Proc Soc Exp Biol Med on December 01, 1957
Uric acid production in gout. J Clin Invest (1961) 3.62
Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest (1959) 2.56
The renal excretion of uric acid in patients with gout and in nongouty subjects. J Clin Invest (1959) 2.29
Tubular secretion of urate in man. J Clin Invest (1959) 1.60
Effect of oral fructose on urate production. Ann Rheum Dis (1974) 1.55
Interrelation of uric acid and ethanol metabolism in man. J Clin Invest (1962) 1.40
The role of lactic acid in the reduced excretion of uric acid in toxemia of pregnancy. J Clin Invest (1960) 1.31
A controlled study of diet in patients with gout. Ann Rheum Dis (1983) 1.14
Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. Bull N Y Acad Med (1958) 1.12
Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J Clin Invest (1984) 1.09
Evidence for a postsecretory reabsorptive site for uric acid in man. J Clin Invest (1973) 1.02
Lipid metabolism in gout. Proc R Soc Med (1966) 0.89
Urate excretion. Proc R Soc Med (1966) 0.83
Clinical significance in alcoholic patients of commonly encountered laboratory test results. West J Med (1992) 0.83
[Influence of parenteral fructose or glucose administration on uric acid formation and phosphate uptake of the human liver]. Z Ernahrungswiss (1975) 0.79
Molecular variation in relation to purine metabolism. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.78
Organic acid excretion patterns in gout. Ann Rheum Dis (1972) 0.75
Diet and alcohol in gout. Br Med J (1967) 0.75
URIC ACID RENAL DISEASE IN ACUTE LEUKEMIA. Calif Med (1964) 0.75
Diurnal variations of renal function in man. J Clin Invest (1950) 3.17
The extrarenal response to acute acid-base disturbances of respiratory origin. J Clin Invest (1955) 3.15
Carbon tetrachloride poisoning in man; the mechanisms of renal failure and recovery. J Clin Invest (1949) 2.80
Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest (1959) 2.56
Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism (1952) 2.38
Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status. Am J Med (1959) 2.25
Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med (1957) 2.24
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
The renal mechanism for urate excretion in man. J Clin Invest (1950) 2.19
Current principles of management in gout. Am J Med (1952) 1.99
EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med (1964) 1.93
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest (1952) 1.77
Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest (1953) 1.71
The use of diamox, a carbonic anhydrase inhibitor, as an oral diuretic in patients with congestive heart failure. N Engl J Med (1953) 1.65
A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J Clin Invest (1953) 1.65
Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med (1955) 1.65
Present status of atherosclerosis as a derangement of lipid metabolism. Am J Med (1953) 1.61
Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients. Am J Med (1950) 1.61
Tubular secretion of urate in man. J Clin Invest (1959) 1.60
Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med (1961) 1.59
Renal function studies in a adult subject with the Fanconi syndrome. Am J Med (1954) 1.58
A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. J Clin Invest (1955) 1.50
Diurnal variations of renal function in congestive heart failure. Proc Soc Exp Biol Med (1950) 1.42
The purine bases of human urine. I. Separation and identification. J Biol Chem (1957) 1.40
Renal function in Wilson's disease. J Clin Invest (1957) 1.34
The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. J Pharmacol Exp Ther (1963) 1.33
A simultaneous study of glycine-N15 incorporation into uric acid and heme, and of Fe59 utilization, in a case of gout associated with polycythemia secondary to congenital heart disease. Am J Med (1953) 1.32
Effects of diet in essential hypertension. I. Baseline study: effects in 86 cases of prolonged hospitalization on regular hospital diet. Am J Med (1950) 1.30
PERCUTANEOUS TRANSFEMORAL ARTERIOGRAPHY: AN ANALYSIS OF THE COMPLICATIONS IN 1,000 CONSECUTIVE CASES. Am J Roentgenol Radium Ther Nucl Med (1964) 1.25
On the biosynthesis of uric acid from glycine-N15 in primary and secondary polycythemia. Am J Med (1956) 1.23
A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians (1961) 1.22
Incorporation of glycine-1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects. Am J Med (1958) 1.21
Some recent advances in the study of uric acid metabolism and gout. Bull N Y Acad Med (1951) 1.20
Primary and secondary gout. Ann Intern Med (1953) 1.19
Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. Arthritis Rheum (1958) 1.18
Origin of urinary creatine in progressive muscular dystrophy. Metabolism (1952) 1.14
SIGNIFICANCE OF THE RENAL CLEARANCE OF URIC ACID IN NORMAL AND GOUTY MAN. Am J Med (1964) 1.13
AN ABNORMALITY OF GLUTAMINE METABOLISM IN PRIMARY GOUT. Am J Med (1963) 1.12
Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. Bull N Y Acad Med (1958) 1.12
Gout, a derangement of purine metabolism. Adv Intern Med (1952) 1.10
Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions. Proc Soc Exp Biol Med (1957) 1.10
Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians (1951) 1.09
The renal clearance and plasma protein binding of aureomycin in man. J Pharmacol Exp Ther (1950) 1.09
MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS. J Clin Invest (1963) 1.09
A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog. Am J Med (1960) 1.08
Biochemical pharmacological considerations of phenylbutazone and its analogues. Ann N Y Acad Sci (1960) 1.08
Prevention and treatment of chronic gouty arthritis. J Am Med Assoc (1955) 1.07
Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man. J Pharmacol Exp Ther (1958) 1.07
Zoxazolamine: physiological disposition, uricosuric properties. Am J Med (1958) 1.04
Effects of adrenocorticotropic hormone (ACTH) in gout. Am J Med (1950) 1.03
Systemic manifestations of hypernephroma; a review of 273 cases. Am J Med (1957) 1.02
Drug reactions characterized by cholestasis associated with intrahepatic biliary tract obstruction. Am J Med (1957) 1.02
ROENTGEN MANIFESTATIONS OF THE SUBCLAVIAN STEAL SYNDROME. Am J Roentgenol Radium Ther Nucl Med (1963) 1.01
Occurrence of methylated purine bases in yeast ribonucleic acid. J Biol Chem (1958) 1.01
The purine bases of human urine. II. Semiquantitative estimation and isotope incorporation. J Biol Chem (1957) 1.00
Ultrafiltrability of plasma urate in man. Proc Soc Exp Biol Med (1953) 0.99
Tubular secretion of urate in the dog. Am J Physiol (1960) 0.98
The effect of a carbonic anhydrase inhibitor, diamox, on human pancreatic secretion. Gastroenterology (1955) 0.98
Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione). Proc Soc Exp Biol Med (1955) 0.97
Hyperuricemia induced by the administration of chlorthalidone and other sulfonamide diuretics. Am J Med (1962) 0.96